Prognostic Relevance of Gene-Environment Interactions in Patients with Dilated Cardiomyopathy Applying the MOGE(S) Classification

Journal of the American College of Cardiology

Volumn 66, Issue 12, 2015, Pages 1313-1323

  Hazebroek, Mark R ^a   Moors, Suzanne ^a   Dennert, Robert ^a   Van Den Wijngaard, Arthur ^b   Krapels, Ingrid ^b   Hoos, Marije ^a   Verdonschot, Job ^a   Merken, Jort J ^a   De Vries, Bart ^b   Wolffs, Petra F ^b   Crijns, Harry J G M ^a   Brunner La Rocca, Hans Peter ^a   Heymans, Stephane ^a,c  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c ROYAL NETHERLANDS ACADEMY OF ARTS AND SCIENCES   (Netherlands)

Author keywords

autoimmune; etiology; toxic; virus

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; MINERALOCORTICOID ANTAGONIST;

ADULT; ARTICLE; CLINICAL FEATURE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE REGISTRY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; ENVIRONMENTAL FACTOR; EVENT FREE SURVIVAL; FEMALE; FOLLOW UP; GENETIC ANALYSIS; GENETIC COUNSELING; GENETIC VARIABILITY; GENOTYPE ENVIRONMENT INTERACTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE BIOPSY; HEART TRANSPLANTATION; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; HUMAN TISSUE; IMMUNOHISTOLOGY; MAJOR CLINICAL STUDY; MALE; MORPHOFUNCTIONAL, ORGAN INVOLVEMENT, GENETIC OR FAMILIAL, ETIOLOGY, STAGE CLASSIFICATION; NETHERLANDS; NEW YORK HEART ASSOCIATION CLASS; OUTCOME ASSESSMENT; PATHOGENESIS; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; SUDDEN CARDIAC DEATH; VIRUS LOAD; CARDIOMYOPATHY, DILATED; CLASSIFICATION; MIDDLE AGED; SEVERITY OF ILLNESS INDEX;

ADULT; CARDIOMYOPATHY, DILATED; FEMALE; GENE-ENVIRONMENT INTERACTION; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; SEVERITY OF ILLNESS INDEX;

EID: 84942549152     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2015.07.023     Document Type: Article

References (31)

1. E. Arbustini, N. Narula, G.W. Dec, and et al. The MOGE(S) classification for a phenotype-genotype nomenclature of cardiomyopathy: endorsed by the World Heart Federation J Am Coll Cardiol 62 2013 2046 2072
2. A.L. Caforio, S. Pankuweit, E. Arbustini, and et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases Eur Heart J 34 2013 2636 2648 2648a-d
3. R. Dennert, H.J. Crijns, and S. Heymans Acute viral myocarditis Eur Heart J 29 2008 2073 2082
4. E.K. Kasper, W.R. Agema, G.M. Hutchins, and et al. The causes of dilated cardiomyopathy: a clinicopathologic review of 673 consecutive patients J Am Coll Cardiol 23 1994 586 590
5. G.M. Felker, W. Hu, J.M. Hare, and et al. The spectrum of dilated cardiomyopathy: the Johns Hopkins experience with 1,278 patients Medicine (Baltimore) 78 1999 270 283
6. J.S. Shinbane, M.A. Wood, D.N. Jensen, and et al. Tachycardia-induced cardiomyopathy: a review of animal models and clinical studies J Am Coll Cardiol 29 1997 709 715
7. T.S. Baman, D.C. Lange, K.J. Ilg, and et al. Relationship between burden of premature ventricular complexes and left ventricular function Heart Rhythm 7 2010 865 869
8. R.E. Hershberger, and J.D. Siegfried Update 2011: clinical and genetic issues in familial dilated cardiomyopathy J Am Coll Cardiol 57 2011 1641 1649
9. B.J. Maron, J.A. Towbin, G. Thiene, and et al. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association scientific statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention Circulation 113 2006 1807 1816
10. J.S. Gottdiener, J. Bednarz, R. Devereux, and et al. American Society of Echocardiography recommendations for use of echocardiography in clinical trials J Am Soc Echocardiogr 17 2004 1086 1119
11. M. Merlo, S.A. Pyxaras, B. Pinamonti, and et al. Prevalence and prognostic significance of left ventricular reverse remodeling in dilated cardiomyopathy receiving tailored medical treatment J Am Coll Cardiol 57 2011 1468 1476
12. R. Dennert, S. Velthuis, S. Schalla, and et al. Intravenous immunoglobulin therapy for patients with idiopathic cardiomyopathy and endomyocardial biopsy-proven high PVB19 viral load Antivir Ther 15 2010 193 201
13. L. Mestroni, B. Maisch, W.J. McKenna, and et al. Guidelines for the study of familial dilated cardiomyopathies: Collaborative Research Group of the European Human and Capital Mobility Project on Familial Dilated Cardiomyopathy Eur Heart J 20 1999 93 102
14. B. Maisch, M. Noutsias, V. Ruppert, and et al. Cardiomyopathies: classification, diagnosis, and treatment Heart Fail Clin 8 2012 53 78
15. P. Elliott, B. Andersson, E. Arbustini, and et al. Classification of the cardiomyopathies: a position statement from the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases Eur Heart J 29 2008 270 276
16. P. Richardson, W. McKenna, M. Bristow, and et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies Circulation 93 1996 841 842
17. S. Piran, P. Liu, A. Morales, and et al. Where genome meets phenome: rationale for integrating genetic and protein biomarkers in the diagnosis and management of dilated cardiomyopathy and heart failure J Am Coll Cardiol 60 2012 283 289
18. E. Grunig, J.A. Tasman, H. Kucherer, and et al. Frequency and phenotypes of familial dilated cardiomyopathy J Am Coll Cardiol 31 1998 186 194
19. M.K. Baig, J.H. Goldman, A.L. Caforio, and et al. Familial dilated cardiomyopathy: cardiac abnormalities are common in asymptomatic relatives and may represent early disease J Am Coll Cardiol 31 1998 195 201
20. R.E. Hershberger, N. Norton, A. Morales, and et al. Coding sequence rare variants identified in MYBPC3, MYH6, TPM1, TNNC1, and TNNI3 from 312 patients with familial or idiopathic dilated cardiomyopathy Circ Cardiovasc Genet 3 2010 155 161
21. D. Li, S.B. Parks, J.D. Kushner, and et al. Mutations of presenilin genes in dilated cardiomyopathy and heart failure Am J Hum Genet 79 2006 1030 1039
22. R.E. Hershberger, S.B. Parks, J.D. Kushner, and et al. Coding sequence mutations identified in MYH7, TNNT2, SCN5A, CSRP3, LBD3, and TCAP from 313 patients with familial or idiopathic dilated cardiomyopathy Clin Transl Sci 1 2008 21 26
23. N. Norton, D. Li, M.J. Rieder, and et al. Genome-wide studies of copy number variation and exome sequencing identify rare variants in BAG3 as a cause of dilated cardiomyopathy Am J Hum Genet 88 2011 273 282
24. N.K. Lakdawala, B.H. Funke, S. Baxter, and et al. Genetic testing for dilated cardiomyopathy in clinical practice J Card Fail 18 2012 296 303
25. K.Y. van Spaendonck-Zwarts, I.A. van Rijsingen, M.P. van den Berg, and et al. Genetic analysis in 418 index patients with idiopathic dilated cardiomyopathy: overview of 10 years' experience Eur J Heart Fail 15 2013 628 636
26. M.R. Taylor, P.R. Fain, G. Sinagra, and et al. Natural history of dilated cardiomyopathy due to lamin A/C gene mutations J Am Coll Cardiol 41 2003 771 780
27. I.A. van Rijsingen, P.A. van der Zwaag, J.A. Groeneweg, and et al. Outcome in phospholamban R14del carriers: results of a large multicentre cohort study Circ Cardiovasc Genet 7 2014 455 465
28. U. Kuhl, M. Pauschinger, M. Noutsias, and et al. High prevalence of viral genomes and multiple viral infections in the myocardium of adults with "idiopathic" left ventricular dysfunction Circulation 111 2005 887 893
29. F. Kuethe, H.H. Sigusch, K. Hilbig, and et al. Detection of viral genome in the myocardium: lack of prognostic and functional relevance in patients with acute dilated cardiomyopathy Am Heart J 153 2007 850 858
30. U. Kuhl, M. Pauschinger, B. Seeberg, and et al. Viral persistence in the myocardium is associated with progressive cardiac dysfunction Circulation 112 2005 1965 1970
31. N.S. Young, and K.E. Brown Parvovirus B19 N Engl J Med 350 2004 586 597